See accompanying notes to unaudited interim condensed consolidated
financial statements.
See accompanying notes to unaudited interim condensed consolidated
financial statements.
See accompanying notes to unaudited interim condensed consolidated
financial statements.
Note 15 includes supplemental cash flow information, non-cash
investing and financing activities and changes in operating assets and liabilities.
See accompanying notes to unaudited interim condensed consolidated
financial statements.
See accompanying notes to unaudited interim condensed consolidated
financial statements.
Note 1. Basis of Presentation and Going
Concern
Nature of Operations - BioHiTech
Global, Inc. (the “Company” or “BioHiTech”) through its wholly-owned and its controlled subsidiaries
provides cost-effective and sustainable environmental management solutions.
Our cost-effective technology solutions
include the patented processing of municipal solid waste into a valuable renewable fuel, biological disposal of food waste on-site,
and proprietary real-time data analytics tools to reduce food waste generation. Our solutions enable businesses and municipalities
of all sizes to lower disposal costs while having a positive impact on the environment. When used individually or in combination,
our solutions lower the carbon footprint associated with waste transportation and can reduce or virtually eliminate landfill usage.
In March 2020, the World Health Organization
declared the outbreak of a novel coronavirus (COVID-19) as a pandemic which continues to spread throughout the United States and
globally. The Company is monitoring the near term and longer term impacts of COVID-19 and the related business and travel restrictions
and changes to behavior intended to reduce its spread, and its impact on operations, financial position, cash flows, inventory,
supply chains, purchasing trends, customer payments, and the industry in general, in addition to the impact on its employees. Due
to the rapid development and fluidity of this situation, the magnitude and duration of the pandemic and its impact on the Company’s
operations, liquidity and financial performance will depend on certain developments, including duration, spread and reemergence
of the outbreak, its impact on our customers, supply chain partners and employees, and the range of governmental and community
reactions to the pandemic, which are uncertain and cannot be fully predicted at this time.
As a result of COVID-19 the implementation
of the Company’s contract with Carnival Corporation has been delayed and the operations of some customers in the restaurant
and hospitality industries have been temporarily interrupted due to governmental actions. For certain existing restaurant and hospitality
customers, the Company has provided a deferral of recurring rental payments for a short time and have modified the rental agreements
to extend the term by the period deferred. These actions have placed a strain on the Company’s cash flows resulting in the
Company executing on cost controls and cash preservation practices that have included reducing executive cash compensation, laying
off non-essential employees, limiting expenses and disbursements, as well as extending vendor payments.
Basis of Presentation - The
accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned and
controlled subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States
of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8
of Regulation S-X. Certain information or footnote disclosures normally included in financial statements prepared in accordance
with GAAP have been condensed or omitted. Accordingly, they do not include all the information and footnotes necessary for a comprehensive
presentation of financial position, results of operations, or cash flows. It is management’s opinion, however, that the accompanying
condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, and the elimination
of intercompany accounts and transactions which are necessary for a fair presentation of the financial position, operating results
and cash flows for the periods presented.
The accompanying condensed consolidated
financial statements should be read in conjunction with the Company’s financial statements for the year ended December 31,
2019, which contains the audited financial statements and notes thereto, for the years ended December 31, 2019 and 2018 included
within the Company’s Form 10-K filed with the Securities and Exchange Commission (“SEC”) on May 22,
2020. The financial information as of December 31, 2019 presented hereto is derived from the audited consolidated financial
statements presented in the Company’s audited consolidated financial statements for the year ended December 31, 2019.
The interim results for the three months ended March 31, 2020 is not necessarily indicative of the results to be expected
for the year ending December 31, 2020 or for any future interim periods.
As of March 31, 2020 and December 31,
2019, the Company’s active wholly-owned subsidiaries were BioHiTech America, LLC, BioHiTech Europe Limited, BHT Financial,
LLC and E.N.A. Renewables LLC, and its controlled subsidiary was Refuel America LLC (60%) and its wholly-owned subsidiaries Apple
Valley Waste Technologies Buyer, Inc., Apple Valley Waste Technologies, LLC, New Windsor Resource Recovery LLC and Rensselaer
Resource Recovery LLC and its controlled subsidiary Entsorga West Virginia LLC (88.7%, 88.7% and 78.2% as of March 31, 2020,
December 31, 2019 and March 31, 2019, respectively). As each of these subsidiaries operate as environmental-based service
companies, we did not deem segment reporting necessary.
Reclassifications to certain prior period
amounts have been made to conform to current period presentation. These reclassifications have no effect on previously reported
net loss.
Going Concern and Liquidity
- For the three months March 31, 2020, the Company had a consolidated net loss of $3,393,974, incurred a consolidated loss
from operations of $2,393,950 and used net cash in consolidated operating activities of $2,515,474. At March 31, 2020, consolidated
total stockholders’ equity amounted to $5,787,541, consolidated stockholders’ equity attributable to parent amounted
to $1,264,636 and the Company had a consolidated working capital deficit of $11,913,331. While the Company had not met certain
of its senior secured note’s financial covenants as of March 31, 2020 (Note 6), subsequent to that date the Company has favorably
renegotiated those covenants and has received a waiver for such non-compliance through June 30, 2020 as it continues to negotiate
further extension of that waiver. Despite its current compliance under the waiver, until such time as the Company regains compliance
or receives a waiver of such covenants for a year beyond the balance sheet date, under current GAAP accounting rules the senior
secured notes amounting to $4,241,578 have been classified as current debt. The Company does not yet have a history of financial
profitability. The Company does not have firm commitments to fund its future operational and strategic plans although it is presently
in the process of raising additional debt for general operations and to support its leasing activities. The Company has used its
Shelf Registration on Form S-3 during September 2019 to raise net proceeds of $3,035,557 through a confidentially marketed
public offering of common shares, has raised $1,495,450 through a private convertible preferred stock offering in March 2020 and
subsequent to March 31, 2020 one of the Company’s subsidiaries was funded $421,300 on May 13, 2020 through the
Paycheck Protection Program.. There is no assurance that the Company will be able to raise sufficient capital or debt to sustain
operations or to pursue other strategic initiatives or that such financing will be on terms that are favorable to the Company.
These factors raise substantial doubt about the Company’s ability to continue as a going concern.
BioHiTech Global, Inc. and Subsidiaries
|
Notes to Unaudited Condensed Consolidated Financial Statements
|
For the Three and Months Ended March 31, 2020 and 2019 and as of March 31, 2020 and December 31, 2019
|
The accompanying consolidated financial
statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities
in the normal course of business. These consolidated financial statements do not include any adjustments relating to the recovery
of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue
as a going concern. The ability of the Company to continue as a going concern is dependent on management’s further implementation
of the Company’s on-going and strategic plans, which include continuing to raise funds through equity and/or debt raises.
Should the Company be unable to raise adequate funds, certain aspects of the on-going and strategic plans may require modification.
Note 2. Summary of Significant Accounting
Policies
The condensed consolidated financial statements
have been prepared by the Company without audit in accordance with the rules and regulations of the SEC and should be read
in conjunction with our audited financial statements for the year ended December 31, 2019. Certain information and footnote
disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted as permitted
by the SEC, although we believe the disclosures that are made are adequate to make the information presented herein not misleading.
Recent Accounting Pronouncements:
The Company has not implemented any recent
accounting pronouncements during the three months ended March 31, 2020.
The Company has not implemented the following
accounting standard:
In June 2016, the FASB issued ASU
2016-13, Measurement of Credit Losses on Financial Instruments. This standard requires an allowance to be recorded for all
expected credit losses for certain financial assets. The new standard introduces an approach, based on expected losses, to estimate
credit losses on certain types of financial instruments. ASU 2016-13 is effective for public companies for interim and annual period
beginning December 15, 2020. Entities are required to apply the standard’s provisions as a cumulative-effect adjustment
to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. The Company has not yet
adopted this update and is currently evaluating the effect this new standard will have on its financial condition and results of
operations.
There have been no other recent accounting
pronouncements or changes in accounting pronouncements that have been issued but not yet adopted that are of significance, or potential
significance, to the Company.
Note 3. Equipment on Operating Leases,
net
Equipment on operating leases consist of
the following:
|
|
March 31,
|
|
|
December 31,
|
|
|
|
2020
|
|
|
2019
|
|
Leased equipment
|
|
$
|
3,175,933
|
|
|
$
|
3,138,951
|
|
Less: accumulated depreciation
|
|
|
(1,521,180
|
)
|
|
|
(1,413,953
|
)
|
Total Equipment on Operating Leases, net
|
|
$
|
1,654,753
|
|
|
$
|
1,724,998
|
|
The Company is a lessor of digester units
under non-cancellable operating lease agreements expiring through September 2025. These leases generally have terms of three
to five years and do not contain stated extension periods or options for the lessee to purchase the underlying assets. At the end
of the leases, the lessee may enter into a new lease or return the asset, which would be available to the Company for releasing.
BioHiTech Global, Inc. and Subsidiaries
|
Notes to Unaudited Condensed Consolidated Financial Statements
|
For the Three and Months Ended March 31, 2020 and 2019 and as of March 31, 2020 and December 31, 2019
|
During the three months ended March 31,
2020 and 2019, revenue under the agreements, which is included in rental, service and maintenance revenue, amounted to $386,254
and $341,665, respectively. During the three months ended March 31, 2020 and 2019, depreciation expense included in rental,
service and maintenance expense, amounted to $115,866 and $101,502, respectively.
The minimum future estimated contractual
payments to be received under these leases as of March 31, 2020 is as follows:
Year ending December 31,
|
|
|
|
2020, remaining period
|
|
$
|
1,024,508
|
|
2021
|
|
|
990,315
|
|
2022
|
|
|
719,049
|
|
2023
|
|
|
457,898
|
|
2024 and thereafter
|
|
|
181,725
|
|
|
|
$
|
3,373,495
|
|
Note 4. HEBioT facility, equipment,
fixtures and vehicles, net
HEBioT facility, equipment, fixtures and
vehicles, net consist of the following:
|
|
March 31,
2020
|
|
|
December 31,
2019
|
|
HEBioT facility
|
|
$
|
31,142,974
|
|
|
$
|
31,142,974
|
|
HEBioT equipment
|
|
|
7,407,096
|
|
|
|
7,388,896
|
|
Computer software and hardware
|
|
|
115,076
|
|
|
|
112,629
|
|
Furniture and fixtures
|
|
|
48,196
|
|
|
|
48,196
|
|
Vehicles
|
|
|
50,319
|
|
|
|
50,319
|
|
|
|
|
38,763,661
|
|
|
|
38,743,014
|
|
Less: accumulated depreciation and amortization
|
|
|
(1,784,311
|
)
|
|
|
(1,321,681
|
)
|
Total HEBioT facility, equipment, fixtures and vehicles, net
|
|
$
|
36,979,350
|
|
|
$
|
37,421,333
|
|
Note 5. MBT Facility Development and
License Costs
MBT Facility Development and License Costs
consist of the following:
|
|
March 31,
2020
|
|
|
December 31,
2019
|
|
MBT Projects
|
|
|
|
|
|
|
|
|
Survey and engineering
|
|
|
259,738
|
|
|
|
235,229
|
|
|
|
|
|
|
|
|
|
|
Technology Licenses
|
|
|
|
|
|
|
|
|
Future site
|
|
|
6,019,200
|
|
|
|
6,019,200
|
|
Martinsburg, West Virginia, net of $126,000 and $94,500 of amortization as of March 31, 2020 and December 31, 2019
|
|
|
1,764,000
|
|
|
|
1,795,500
|
|
Total Technology Licenses
|
|
|
7,783,200
|
|
|
|
7,814,700
|
|
Total MBT Facility Development and License Costs
|
|
$
|
8,042,938
|
|
|
$
|
8,049,929
|
|
MBT Facility Development Costs -
During 2018, the Company commenced initial development of a project in Rensselaer, NY. As of March 31, 2020, the Company
has received local permits and has filed the required state permit applications, which are undergoing review by the New York State
Department of Environmental Conservation.
Technology License Agreement –
Future Facility - The royalty payment for the license amounted to $6,019,200. This Technology License Agreement can be
utilized at a future project and will be amortized once the facility is in operation.
Technology License Agreement –
Martinsburg, West Virginia - In connection with the 2018 acquisition accounting applied to Entsorga West Virginia
acquisition, the License Agreement was valued at $1,890,000. During the three months ending March 31, 2020 amounted to $31,500.
Amortization of the License Agreement commenced with the facility becoming operational on March 31, 2019 and there was no
amortization for the three months ended Mach 31, 2019.
BioHiTech Global, Inc. and Subsidiaries
|
Notes to Unaudited Condensed Consolidated Financial Statements
|
For the Three and Months Ended March 31, 2020 and 2019 and as of March 31, 2020 and December 31, 2019
|
Note 6. Line of Credit, Promissory Notes
Payable, Notes Payable, Advances, and Long-Term Debts
Line of Credit, Promissory Notes Payable,
Notes Payable, Advances, and Long-Term Debts consist of the following:
|
|
March 31, 2020
|
|
|
December 31, 2019
|
|
|
|
Total
|
|
|
Related
Party
|
|
|
Total
|
|
|
Related
Party
|
|
Line of credit
|
|
$
|
1,481,356
|
|
|
$
|
-
|
|
|
$
|
1,479,848
|
|
|
$
|
-
|
|
Senior secured promissory note
|
|
|
4,241,578
|
|
|
|
-
|
|
|
|
4,160,490
|
|
|
|
-
|
|
Junior promissory note
|
|
|
954,885
|
|
|
|
954,885
|
|
|
|
949,434
|
|
|
|
949,434
|
|
Note payable
|
|
|
100,000
|
|
|
|
-
|
|
|
|
100,000
|
|
|
|
-
|
|
Advances from related parties (See Note 14 Related Parties)
|
|
|
1,410,000
|
|
|
|
1,410,000
|
|
|
|
210,000
|
|
|
|
210,000
|
|
Long term debt - current and long-term portion
|
|
|
11,345
|
|
|
|
-
|
|
|
|
12,806
|
|
|
|
-
|
|
Line of Credit — The
Credit Agreement and Note with Comerica does not have any financial covenants, carries interest at the rate of 3%, plus either
the Comerica prime rate or a LIBOR-based rate, (5.58% and 5.71% as of March 31, 2020 and December 31, 2019, respectively)
and matured on January 1, 2020, which was subsequently extended to March 31, 2020 and remains outstanding as of the date
of this filing. The Company expects to obtain an amended agreement through the remainder of 2020. The line of credit is secured
by the assets of BHT Financial, LLC and is personally guaranteed by the Company’s Chief Executive Officer, Frank E. Celli
and James D. Chambers, a director.
Michaelson Senior Secured Term Promissory
Financing — Company and several of the Company’s wholly-owned subsidiaries have a Note Purchase and Security
Agreement with Michaelson Capital Special Finance Fund II, L.P. (“ MCSFF ”) for a senior secured term promissory note
in the principal amount of $5,000,000 (the “Note”). The Note is not convertible and accrues interest at the rate of
10.25% per annum. The Note provides for certain financial covenants that were not met as of March 31, 2020. While the Company had
not met certain of its senior secured note’s financial covenants as of March 31, 2020, subsequent to that date the Company
has favorably renegotiated those covenants and has received a waiver for such non-compliance through June 30, 2020 as it continues
to negotiate further extension of that waiver. Despite its current compliance under the waiver, until such time as the Company
regains compliance or receives a waiver of such covenants for a year beyond the balance sheet date, under current GAAP accounting
rules the senior secured notes amounting to $4,241,578 have been classified as current debt. As of December 31, 2019 those
certain financial covenants were not met and a waiver of such was granted by MCSFF through January 1, 2021 with the condition that
the parties negotiate new financial covenants, which were concluded subsequent to March 31, 2020. As of December 31, 2019, the
Note has been classified based on the contractual repayment schedule. For purposes of the following maturity schedule, as the Company
believes that it will achieve compliance with the revised financial covenants and MCSFF has a history of waiving non-compliance
with financial covenants, the maturities have been presented based upon the contractual repayment terms in effect as of March 31,
2020. The Note is contractually scheduled to be repaid in eight, equal, quarterly installments of $625,000 commencing on May 15,
2021 and ending February 2, 2023 (the “Maturity Date”).
Note
Payable — As of March 31, 2020 and December 31, 2019, the note, with interest at 10%, had a remaining
balance outstanding of $100,000 and matured on January 1, 2020 and remains outstanding as of the date of this filing. The
Company expects to amend the agreement to extend the maturity date through the remainder of 2020.
Contractual Maturities of Senior
Secured, Junior Promissory, Notes Payable and Long Term Debt — As of March 31, 2020, excluding discounts and
deferred finance costs, which are being amortized as interest expense, are as follow:
Year Ending December 31,
|
|
Amortizing
|
|
|
Non-
Amortizing
|
|
|
Total
|
|
2020 (Remaining)
|
|
$
|
3,144
|
|
|
$
|
100,000
|
|
|
$
|
103,144
|
|
2021
|
|
|
4,380
|
|
|
|
1,875,000
|
|
|
|
1,879,380
|
|
2022
|
|
|
3,821
|
|
|
|
2,500,000
|
|
|
|
2,503,821
|
|
2023
|
|
|
-
|
|
|
|
625,000
|
|
|
|
625,000
|
|
2024 and thereafter
|
|
|
-
|
|
|
|
1,044,477
|
|
|
|
1,044,477
|
|
Total
|
|
$
|
11,345
|
|
|
$
|
6,144,477
|
|
|
$
|
6,155,822
|
|
Note 7. Entsorga West Virginia, LLC WVEDA Solid Waste Disposal
Revenue Bonds
During 2016, Entsorga West Virginia LLC
(the “Borrower”) was issued $25,000,000 in Non-Recourse Solid Waste Revenue Bonds from the West Virginia Economic Development
Authority (the “WVEDA Bonds”). The WVEDA Bonds were issued in two series with one for $7,535,000 bearing interest at
6.75% per annum with a maturity date of February 1, 2026 and the second for $17,465,000 bearing interest at 7.25% per annum
with a maturity of February 1, 2036. Both series were issued at par. The 2026 series was payable with interest-only payments
through February 1, 2019 then annual payments of principal and semi-annual payments of interest through maturity. The 2036
series is payable with interest-only payments through February 1, 2019 then annual payments of principal and semi-annual payments
of interest through maturity. Repayment of principal is by way of sinking fund.
BioHiTech Global, Inc. and Subsidiaries
|
Notes to Unaudited Condensed Consolidated Financial Statements
|
For the Three and Months Ended March 31, 2020 and 2019 and as of March 31, 2020 and December 31, 2019
|
During 2018, the 2016 Indenture Trust and
Loan Agreement were amended and restated effective November 1, 2018. These amendments provided for a third series of bonds
amounting to $8,000,000 bearing interest at 8.75% per annum with a maturity date of February 1, 2036, with special event triggered
pre-payment requirements. This series was issued at par. The 2036 series is payable with interest-only payments through February 1,
2020 then annual payments of principal and semi-annual payments of interest through maturity. Repayment is by way of sinking fund.
The outstanding balance of the WVEDA Bonds
as of March 31, 2020 and December 31, 2019 is $33,000,000, which is presented net of unamortized debt issuance costs
amounting to $2,207,759 as of March 31, 2020 and December 31, 2019, less associated amortization of $460,492 and $415,185
as of March 31, 2020 and December 31, 2019, respectively, which includes amortization prior to the Company’s control
acquisition in 2018. Amortization is calculated on the effective interest method, which is included in interest expense in the
accompanying consolidated statements of operations and comprehensive loss.
The loan agreement and indenture of trust
place restrictions on the Borrower and its members regarding additional encumbrances on the property, disposition of the property,
and limitations on equity distributions. The loan agreement also provides for financial covenants, which became effective on September 30,
2019. As of March 31, 2020 and December 31, 2019 the Company was not in compliance with all of the financial covenants
and subsequently was in default on a principal repayment due in February 2020 and has entered into a forbearance agreement
with the bond trustee that provides, they will not accelerate the repayment of the bonds due to the defaults through April 2,
2021.
The future sinking fund payments by the Borrower as of March 31,
2020 are as follow:
Year Ending December 31,
|
|
2016 Issue
2026 Series
|
|
|
2016 Issue
2036 Series
|
|
|
2018 Issue
2036 Series
|
|
|
Total
|
|
2020 (remaining)
|
|
$
|
1,160,000
|
|
|
$
|
-
|
|
|
$
|
230,000
|
|
|
$
|
1,390,000
|
|
2021
|
|
|
1,215,000
|
|
|
|
-
|
|
|
|
255,000
|
|
|
|
1,470,000
|
|
2022
|
|
|
900,000
|
|
|
|
-
|
|
|
|
275,000
|
|
|
|
1,175,000
|
|
2023
|
|
|
965,000
|
|
|
|
-
|
|
|
|
300,000
|
|
|
|
1,265,000
|
|
2024 and thereafter
|
|
|
3,295,000
|
|
|
|
17,465,000
|
|
|
|
6,940,000
|
|
|
|
27,700,000
|
|
Total
|
|
$
|
7,535,000
|
|
|
$
|
17,465,000
|
|
|
$
|
8,000,000
|
|
|
$
|
33,000,000
|
|
In connection with the November 1,
2018 amendment and restatement of the WVEDA Bonds, Comerica Bank issued a standby letter of credit in the amount of $1,250,000
for the benefit of the WVEDA Bond trustee that is collateralized by the Company’s cash.
Note 8. Equity and Equity Transactions
The Company has 50,000,000 shares of its
$0.0001 par common stock and 10,000,000 shares of blank check preferred stock authorized by its shareholders. As of March 31,
2020 and December 31, 2018, 17,417,288 and 17,300,899 shares of common stock have been issued; and 3,209,210 and 3,179,120
shares, respectively, of preferred stock have been designated in five series of shares, which have a total of $1,192,619 in accumulated,
but undeclared preferential dividends as of March 31, 2020, as follows:
|
|
Designated
|
|
|
Par
|
|
|
Stated
|
|
|
Shares Outstanding
|
|
Designation
|
|
Shares
|
|
|
Value
|
|
|
Value
|
|
|
March 31, 2020
|
|
|
December 31, 2019
|
|
Series A Convertible Preferred Stock
|
|
|
333,401
|
|
|
$
|
0.0001
|
|
|
$
|
5.00
|
|
|
|
145,312
|
|
|
|
145,312
|
|
Series B Convertible Preferred Stock
|
|
|
1,111,200
|
|
|
|
0.0001
|
|
|
$
|
5.00
|
|
|
|
-
|
|
|
|
-
|
|
Series C Convertible Preferred Stock
|
|
|
1,000,000
|
|
|
|
0.0001
|
|
|
$
|
10.00
|
|
|
|
427,500
|
|
|
|
427,500
|
|
Series D Convertible Preferred Stock
|
|
|
20,000
|
|
|
|
0.0001
|
|
|
$
|
100.00
|
|
|
|
18,850
|
|
|
|
18,850
|
|
Series E Convertible Preferred Stock
|
|
|
714,519
|
|
|
|
0.0001
|
|
|
$
|
2.64
|
|
|
|
264,519
|
|
|
|
264,519
|
|
Series F Convertible Preferred Stock
|
|
|
30,090
|
|
|
|
0.0001
|
|
|
$
|
115.00
|
|
|
|
13,045
|
|
|
|
-
|
|
Under the terms of the Company’s
senior lender agreements, the Company is restricted from paying dividends in cash, but is allowed to pay dividends in common stock.
The Company, since its merger in 2015, has not paid any cash or stock dividends on common stock.
The consolidated financial statements include
less than 100% owned and controlled subsidiaries and include equity attributable to non-controlling interests that take the form
of the underlying legal structures of the less than 100% owned subsidiaries. Entsorga West Virginia LLC through its limited liability
agreement and the agreements related to its WVEDA Bonds have restrictions on distributions to and loans to owners while the WVEDA
Bonds are outstanding.
BioHiTech Global, Inc. and Subsidiaries
|
Notes to Unaudited Condensed Consolidated Financial Statements
|
For the Three and Months Ended March 31, 2020 and 2019 and as of March 31, 2020 and December 31, 2019
|
Series F
Convertible Preferred Stock — On March 9, 2020 the Company designated a new series of preferred stock
and subsequently on March 18, 2020 had an initial closing of $1,500,000 on 13,045 shares of the new series of preferred stock
and 178,597 common stock warrants and are presented net of $50,836 in warrant valuations and $4,550 in issuance costs. The newly
designated series, the Series F Redeemable, Convertible Preferred Stock (the “Sr. F Preferred Stock”) is comprised
of 30,090 shares with a par value of $0.0001 per share and a stated value per share of $115.00 that has a dividend rate of 9%.
The Sr. F Preferred Stock is convertible by the holder at any time at a conversion rate of $2.10, subject to certain antidilution
adjustments and is redeemable by the Company after 24 months at its stated value, plus any outstanding accrued or accumulated dividends
for cash, or if the Company’s common stock is trading over $3.00 per share and has daily trading volume of over 50,000 shares,
for the Company’s common stock at the conversion rate in effect at the time. In connection with the offering of the Sr. F
Preferred Stock, the Company also issued 178,597 warrants that expire in five years to acquire the Company’s common stock
at $2.30 per share.
Warrants
— In connection with the issuance of convertible debt, preferred and common stock and in connection with
services provided, the Company has the 4,852,858 warrants to acquire the Company’s common stock outstanding as of March 31,
2020, as follows:
Expiring During the Year
Ending December 31,
|
|
Warrant
Shares
|
|
|
Exercise Price
per Share
|
|
|
Weighted
Average
Exercises
Price
per Share
|
|
2020
|
|
|
22,860
|
|
|
|
$3.50
|
|
|
$
|
3.50
|
|
2021
|
|
|
1,768,516
|
|
|
|
$1.80 to $3.75
|
|
|
$
|
3.25
|
|
2022
|
|
|
1,699,861
|
|
|
|
$1.80 to $5.00
|
|
|
$
|
2.60
|
|
2023
|
|
|
740,749
|
|
|
|
$1.80
|
|
|
$
|
1.80
|
|
2024
|
|
|
385,945
|
|
|
|
$1.80
|
|
|
$
|
1.80
|
|
2025
|
|
|
234,927
|
|
|
|
$2.25 to $2.30
|
|
|
$
|
2.29
|
|
The following table summarizes the outstanding
warrant activity for the three months ended March 31, 2020:
Outstanding, January 1, 2020
|
|
|
4,674,261
|
|
Issued as a result of Series F Convertible Preferred Stock offering
|
|
|
178,597
|
|
Exercised
|
|
|
-
|
|
Expired
|
|
|
-
|
|
Outstanding, March 31, 2020
|
|
|
4,852,858
|
|
Note 9. Equity Incentive Plans
The Company has two equity incentive plans:
2015 Equity Incentive Plan —
During 2015, the Company established the BioHiTech Global, Inc. 2015 Equity Incentive Plan, which is available to eligible
employees, directors, consultants and advisors of the Company and its affiliates. The plan allows for the granting of incentive
stock options, nonqualified stock options, reload options, stock appreciation rights, and restricted stock representing up to 750,000
shares. The Plan is administered by the Compensation Committee of the Board of Directors.
2017 Executive Incentive Plan —
During 2017, the shareholders approved the 2017 Executive Incentive Plan, which is available to eligible employees, directors,
consultants and advisors of the Company and its affiliates. The plan allows for the granting of incentive stock options, nonqualified
stock options, reload options, stock appreciation rights, and restricted stock representing up to 1,000,000 shares. The Plan is
administered by the Compensation Committee of the Board of Directors.
Effective January 30, 2020, the Company
granted nonqualified options for 155,450 shares and 269,060 restricted stock units. The options granted had a fair value of $162,959
using the Black-Scholes option pricing model with the following assumptions: risk-free interest rate of 1.44%, expected dividend
yield of 0%, expected volatility of 49.24% and expected term in years of from 1.00 to 2.92 years. The restricted stock units had
a value of $538,120 based on the market value on the date of the grants and a weighted average vesting period of 0.75 years.
BioHiTech Global, Inc. and Subsidiaries
|
Notes to Unaudited Condensed Consolidated Financial Statements
|
For the Three and Months Ended March 31, 2020 and 2019 and as of March 31, 2020 and December 31, 2019
|
Compensation expense related to stock options
and restricted stock for the three months ended March 31, was:
|
|
2020
|
|
|
2019
|
|
Stock options
|
|
$
|
48,460
|
|
|
$
|
58,388
|
|
Restricted stock
|
|
|
231,745
|
|
|
|
239,361
|
|
Total
|
|
$
|
280,205
|
|
|
$
|
297,749
|
|
Compensation expense related to stock options
and restricted stock for the three months ended March 31, are reflected in the following captions within operating expenses
in the condensed consolidated statements of operations and comprehensive loss:
|
|
2020
|
|
|
2019
|
|
Rental, service and maintenance
|
|
$
|
3,317
|
|
|
$
|
5,755
|
|
Selling, general and administrative
|
|
|
276,888
|
|
|
|
291,994
|
|
Total
|
|
$
|
280,205
|
|
|
$
|
297,749
|
|
The following summarizes the Company’s
stock option activity for the three months ended March 31, 2020:
|
|
Number of
Options
|
|
|
Weighted
Average
Exercise
Price
|
|
|
Weighted
Average
Remaining
Contractual
Life
(in Years)
|
|
|
Aggregate
Intrinsic Value
|
|
Outstanding – January 1, 2020
|
|
|
363,826
|
|
|
$
|
3.71
|
|
|
|
7.34
|
|
|
|
-
|
|
Granted
|
|
|
155,450
|
|
|
|
2.00
|
|
|
|
-
|
|
|
|
-
|
|
Exercised
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Forfeited, Canceled or Expired
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Outstanding – March 31, 2020
|
|
|
519,276
|
|
|
$
|
3.20
|
|
|
|
7.91
|
|
|
|
-
|
|
Exercisable – March 31, 2020
|
|
|
241,651
|
|
|
$
|
3.67
|
|
|
|
6.59
|
|
|
|
-
|
|
The following summarizes the Company’s
restricted stock unit activity for the three months ended March 31, 2020:
Balance, January 1, 2020
|
|
|
291,730
|
|
Grants
|
|
|
269,060
|
|
Forfeited
|
|
|
-
|
|
Vested
|
|
|
-
|
|
Balance, March 31, 2020
|
|
|
560,790
|
|
Note 10. Revenue
The Company recognizes revenue as services
are performed or products are delivered and generally recognize revenue for the gross amount of consideration received as we are
generally the primary obligor (or principal) in our contracts with customers as we hold complete responsibility to the customer
for contract fulfillment. We record amounts collected from customers for sales tax on a net basis.
Disaggregation of Revenue —
The disaggregation of revenue for the three months ended March 31, is as follows:
|
|
2020
|
|
|
2019
|
|
Revenue Type:
|
|
|
|
|
|
|
|
|
Rental of digesters
|
|
$
|
386,254
|
|
|
$
|
341,665
|
|
Services
|
|
|
601,433
|
|
|
|
372,975
|
|
Product sales
|
|
|
371,654
|
|
|
|
23,061
|
|
Total Revenue
|
|
$
|
1,359,341
|
|
|
$
|
737,701
|
|
BioHiTech Global, Inc. and Subsidiaries
|
Notes to Unaudited Condensed Consolidated Financial Statements
|
For the Three and Months Ended March 31, 2020 and 2019 and as of March 31, 2020 and December 31, 2019
|
Note 11. Risk Concentrations
The Company operates as a single segment
on a worldwide basis through its subsidiaries, resellers and independent sales agents. Gross revenues and net non-current tangible
assets on a domestic and international basis are as follows:
|
|
United
States
|
|
|
International
|
|
|
Total
|
|
2020:
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, for the three months ended March 31, 2020
|
|
$
|
1,225,910
|
|
|
$
|
133,431
|
|
|
$
|
1,359,341
|
|
Non-current tangible assets, as of March 31, 2020
|
|
|
38,330,741
|
|
|
|
316,862
|
|
|
|
38,647,603
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2019:
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, for the three months ended March 31, 2019
|
|
$
|
641,646
|
|
|
$
|
96,055
|
|
|
$
|
737,701
|
|
Non-current tangible assets, as of December 31, 2019
|
|
|
38,803,333
|
|
|
|
355,825
|
|
|
|
39,159,658
|
|
Credit risk — Financial
instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and accounts receivable.
The Company minimizes credit risk associated
with cash by periodically evaluating the credit quality of its primary financial institutions. At times, the Company’s cash
may be uninsured or in deposit accounts that exceed the Federal Deposit Insurance Corporation (“FDIC”) in the USA and
the Financial Conduct Authority (“FCA”) in the UK insurance limits. Through March 31, 2020, the Company had not
experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Major customers — During the three
months ended March 31, 2020, one customer represented at least 10% of revenues, accounting for 35.9% (Gold Medal Group, LLC,
an affiliated entity, “GMG”) of revenues. During the three months ended March 31, 2019, one customer represented
at least 10% of revenues, accounting for 34.6% (GMG).
As of March 31, 2020 one customer
represented at least 10% of accounts receivable, accounting for 74.8% (GMG) of accounts receivable. As of December 31, 2019
one customer represented at least 10% of accounts receivable, accounting for 58.9% (GMG) of accounts receivable.
Vendor concentration —
During the three months ended March 31, 2020, one vendor represented at least 10% of costs of revenue, accounting for 24.5%
(GMG). During the three months ended March 31, 2019, no vendors represented at least 10% of the combined cost of revenues.
As of March 31, 2020, excluding construction
payables and other professional fees, one vendor represented at least 10% of accounts payable accounting for 45.5% (GMG) of accounts
payable. As of December 31, 2019, one vendor represented at least 10% of accounts payable accounting for 54.4% (GMG) of accounts
payable.
Affiliate relationship —
GMG owns a 40% interest in Refuel America, LLC, a consolidated subsidiary of the Company. GMG’s subsidiaries, which are not
consolidated in the Company’s financial statements have several business relationships with the Company and its subsidiaries
that result in revenues and expenses noted above. See Note 14. Related Party Transactions.
Note 12. Commitments and Contingencies
During the three months ended March 31,
2020 the Company was involved in the following legal matters.
On February 7, 2018, Lemartec Corporation
(“Lemartec”) filed a complaint against the Company in the United States District Court for the Northern District of
West Virginia arising out of the construction of the Company’s resource recovery facility in Martinsburg, West Virginia alleging
breach of contract and unjust enrichment. The Company has filed its answer and counterclaims for damages against Lemartec and cross
claims against Lemartec’s performance bond surety, Philadelphia Indemnity Insurance Company. The trial was scheduled to begin
in August 2020. Prior to the start of the trial, on March 12, 2020 the Company entered into a settlement agreement that
detailed the full and final mutual release. The settlement agreement provides that the Company pay Lemartec $775,000 in installments
of $475,000 within 60 days of the execution of the settlement agreement and $25,000 each month thereafter for 12 months. The Company’s
consolidated financial statements as of December 31, 2019 reflects this liability given the nature of the subsequent event.
BioHiTech Global, Inc. and Subsidiaries
|
Notes to Unaudited Condensed Consolidated Financial Statements
|
For the Three and Months Ended March 31, 2020 and 2019 and as of March 31, 2020 and December 31, 2019
|
It is management’s opinion that the
resolution of this known claim will not materially affect the Company’s future financial position, results of operations,
or cash flows.
From time to time, the Company may be involved
in other legal matters arising in the ordinary course of business. While the Company believes that such matters are currently not
material, there can be no assurance that matters arising in the ordinary course of business for which the Company is, or could
be, involved in litigation, will not have a material adverse effect on its business, financial condition or results of operations
Note 13. Leases
Effective January 1, 2019, the Company
implemented Accounting Standards Codification 842, Leases. The Company utilized the optional transition method to assess the impact
of this guidance on the Company’s financial statements and related disclosures, including the increase in the assets and
liabilities on our balance sheet from lessee perspective. The Company completed a comprehensive review of its leases that were
impacted by the new guidance. As part of the adoption, the Company elected the ‘package of practical expedients,’ which
permits the Company not to reassess under the new standard the Company’s prior conclusions about lease identification, lease
classification and initial direct costs, therefore the Company did not restate prior comparative periods.
The Company rents its headquarters and
attached warehousing space from a related party (see Note 14) and has a land lease relating to the Martinsburg, WV HEBioT facility
under operating leases. The HEBioT facility land lease has an initial term of 30 years, plus four 5-year extensions. For purposes
of our determination of lease liabilities, extensions were not included. As the leases do not provide an implicit rate, the Company
used incremental borrowing rates in determining the present value of lease payments. For the HEBioT facility land lease a rate
of 11% was utilized and a rate of 10.25% was used on the other leases. The current portion of the lease liabilities of $121,510
is included in accrued expenses and liabilities. Total lease costs under operating leases amounted to $55,356 and $67,532 for the
three months ended March 31, 2020 and 2019, respectively. Maturities of lease liabilities under these leases, which have a
weighted average remaining term of 25.6 years, as of March 31, 2020 is:
Year Ending December 31,
|
|
|
|
2020 (remaining)
|
|
$
|
95,521
|
|
2021
|
|
|
109,000
|
|
2022
|
|
|
113,000
|
|
2023
|
|
|
113,000
|
|
2024 and thereafter
|
|
|
2,980,750
|
|
Total lease payments
|
|
|
3,411,271
|
|
Less imputed interest
|
|
|
(2,372,788
|
)
|
Present value of lease liabilities
|
|
$
|
1,038,483
|
|
The Company operating cash flows for operating
leases amounting to $51,406 and $46,034 for the three months ended March 31, 2020 and 2019, respectively.
Note 14. Related Party Transactions
Related parties include Directors, Senior
Management Officers, and shareholders, plus their immediate family, who own a 5% or greater ownership interest at the time of a
transaction. Related parties also include GMG and its subsidiaries as a result of its 40% interest in Refuel America, LLC (“Refuel”),
a consolidated entity of the Company.
During 2018 GMG acquired as regional waste
management entity, Apple Valley Waste (“AVW”), with operations located in West Virginia, Maryland and Pennsylvania.
As part of this acquisition, GMG also acquired AVW’s interests in EWV that were contributed to Refuel. Prior to GMG’s
acquisition of AVW and the Company’s investments and control acquisition of EWV, in order for EWV to receive the proceeds
from the Entsorga West Virginia, LLC WVEDA Non-Recourse Solid Waste Disposal Revenue Bonds, EWV and AWV had entered into several
agreements relating to business services, solid waste delivery and disposal.
BioHiTech Global, Inc. and Subsidiaries
|
Notes to Unaudited Condensed Consolidated Financial Statements
|
For the Three and Months Ended March 31, 2020 and 2019 and as of March 31, 2020 and December 31, 2019
|
The table below presents the face amount
of direct related party assets and liabilities and other transactions or conditions as of or during the periods indicated.
|
|
|
|
March 31,
2020
|
|
|
December 31,
2019
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
(a) (b)
|
|
$
|
1,860,171
|
|
|
$
|
1,370,867
|
|
Intangible assets, net, included in other assets
|
|
(c)
|
|
|
35,349
|
|
|
|
40,399
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
(c) (d) (e) (f)
|
|
|
2,654,592
|
|
|
|
2,531,034
|
|
Accrued interest payable
|
|
|
|
|
101,907
|
|
|
|
46,796
|
|
Long term accrued interest
|
|
(g)
|
|
|
1,567,311
|
|
|
|
1,510,193
|
|
Advance from related party
|
|
(h)
|
|
|
1,410,000
|
|
|
|
210,000
|
|
Junior promissory note
|
|
(g)
|
|
|
954,885
|
|
|
|
949,434
|
|
Other:
|
|
|
|
|
|
|
|
|
|
|
Line of credit guarantee
|
|
(i)
|
|
|
1,481,356
|
|
|
|
1,479,848
|
|
The table below presents direct related
party expenses or transactions for the three months ended March 31,2020 and 2019. Compensation and related costs for employees
of the Company are excluded from the table below.
|
|
|
|
2020
|
|
|
2019
|
|
Management advisory and other fees
|
|
(a)
|
|
$
|
75,000
|
|
|
$
|
250,000
|
|
HEBioT revenue
|
|
(b)
|
|
|
406,958
|
|
|
|
-
|
|
Operating expenses - HEBioT
|
|
(d)
|
|
|
298,803
|
|
|
|
-
|
|
Operating expenses – Selling, general and administrative
|
|
(e)
|
|
|
25,156
|
|
|
|
24,537
|
|
Operating expenses - Selling, general and administrative
|
|
(c) (f)
|
|
|
110,650
|
|
|
|
18,750
|
|
Interest expense
|
|
|
|
|
97,948
|
|
|
|
63,628
|
|
Debt guarantee fees
|
|
(i)
|
|
|
16,875
|
|
|
|
16,875
|
|
Summary notes:
a -
|
Management Advisory Fees
|
|
f -
|
Business Services Fees
|
|
b -
|
HEBioT Disposal Revenues
|
|
g -
|
Junior Promissory Note
|
|
c -
|
Distribution Agreement
|
|
h -
|
Advances from Related Parties
|
|
d -
|
Disposal costs
|
|
i -
|
Line of Credit
|
|
e -
|
Facility Lease
|
|
|
|
|
Advances
from Related Parties - The Company’s Chief Executive Officer (the “Officer”) on occasion advances
the Company funds for operating and capital purposes. The advances bear interest at 13% and are unsecured and due on demand. During
the three months ended March 31,2020 the Officer advanced $1,000,000 to the Company. There are no financial covenants related
to this advance and there are no formal commitments to extend any further advances. In addition, during the three months ended
March 31, 2020 another officer advanced $200,000 to the Company.
BioHiTech Global, Inc. and Subsidiaries
|
Notes to Unaudited Condensed Consolidated Financial Statements
|
For the Three and Months Ended March 31, 2020 and 2019 and as of March 31, 2020 and December 31, 2019
|
Note 15. Supplemental Consolidated
Statement of Cash Flows Information
Changes
in non-cash operating assets and liabilities, as well as other supplemental cash flow disclosures for the three months ended March 31,
are as follows.
|
|
2020
|
|
|
2019
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
$
|
(324,890
|
)
|
|
$
|
48,266
|
|
Inventory
|
|
|
31,981
|
|
|
|
76,930
|
|
Prepaid expenses and other assets
|
|
|
(25,989
|
)
|
|
|
(36,508
|
)
|
Accounts payable
|
|
|
672,061
|
|
|
|
3,088,732
|
|
Accrued interest payable
|
|
|
(525,392
|
)
|
|
|
(399,764
|
)
|
Accrued expenses
|
|
|
(9,591
|
)
|
|
|
(2,668,827
|
)
|
Deferred revenue
|
|
|
11,977
|
|
|
|
12,142
|
|
Customer deposits
|
|
|
(38,000
|
)
|
|
|
4,351
|
|
Net change in operating assets and liabilities
|
|
$
|
(207,843
|
)
|
|
$
|
125,322
|
|
|
|
|
|
|
|
|
|
|
Supplementary cash flow information:
|
|
|
|
|
|
|
|
|
Cash paid during the periods for:
|
|
|
|
|
|
|
|
|
Interest
|
|
$
|
1,387,402
|
|
|
$
|
1,082,526
|
|
Income taxes
|
|
|
-
|
|
|
|
-
|
|
|
|
2020
|
|
|
2019
|
|
Supplementary Disclosure of Non-Cash Investing and Financing Activities:
|
|
|
|
|
|
|
|
|
Transfer of inventory to leased equipment
|
|
$
|
67,604
|
|
|
$
|
6,884
|
|
Accrual of Series A preferred stock dividends
|
|
|
17,564
|
|
|
|
18,372
|
|
Payment of Series A preferred stock dividends in common stock
|
|
|
25,000
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Cash and Restricted Cash:
|
|
|
|
|
|
|
|
|
Cash
|
|
$
|
1,934,846
|
|
|
$
|
1,374,564
|
|
Restricted cash (current)
|
|
|
1,137,714
|
|
|
|
2,137,456
|
|
Restricted cash (non-current)
|
|
|
2,563,978
|
|
|
|
2,532,933
|
|
Total cash and restricted cash at the end of the period
|
|
$
|
5,636,538
|
|
|
$
|
6,044,953
|
|
Note 16. Subsequent Events
The Company evaluates subsequent events
and transactions that occur after the balance sheet date up to the date that the financial statements are available to be issued.
Any material events that occur between the balance sheet date and the date that the financial statements were available for issuance
are disclosed as subsequent events, while the financial statements are adjusted to reflect any conditions that existed at the balance
sheet date. Based upon this review, except as disclosed within the footnotes or as discussed below, the Company did not identify
any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements.
BioHiTech Global, Inc. and Subsidiaries
|
Notes to Unaudited Condensed Consolidated Financial Statements
|
For the Three and Months Ended March 31, 2020 and 2019 and as of March 31, 2020 and December 31, 2019
|
On January 30, 2020 the Chief Executive
Officer and another officer advanced $1,050,000 and $200,000 to the Company, which the Company repaid $275,000 and $200,000 on
April 27, 2020, respectively.
The Company has applied for funds under
the Paycheck Protection Program in May 2020 for one of its subsidiaries. The application for these funds requires the Company
to, in good faith, certify that the current economic uncertainty made the loan request necessary to support the ongoing operations
of the Company. This certification further requires the Company to take into account its current business activity and its ability
to access other sources of liquidity sufficient to support ongoing operations in a manner that is not significantly detrimental
to the business. The application amounting to $421,300 was approved and was funded on May 13, 2020. The forgiveness of the
loan attendant to these funds, is dependent on the Company qualifying for the forgiveness of such loan based on its future adherence
to the forgiveness criteria.
On April 6, 2020 the Company closed
on an additional $65,000 on 566 shares of the Series F of preferred stock and 7,750 common stock warrants.
Effective April 1, 2020 the Company and GMG mutually agreed
to reduce the scope and its annual fee related to the management agreement in place from $300,000 to $100,000 per year.
Note 17. Condensed Consolidating Financial Information
The WVEDA Solid Waste Disposal Revenue
Bond obligations of Entsorga West Virginia LLC are not guaranteed by its members, including the Company, however the membership
interests of Entsorga West Virginia LLC are pledged, and the debt agreements provide restrictions prohibiting distributions to
the members, including equity distributions or providing loans or advances to the members.
The following pages present the Company’s
consolidating balance sheet as of March 31, 2020 and December 31, 2019 and its condensed consolidating statements of
operations and cash flows for the three months ended March 31, 2020 and 2019, for Entsorga West Virginia LLC and the Parent
consolidated with other Company subsidiaries not subject to the WVEDA Solid Waste Disposal Revenue Bond restrictions and the elimination
entries necessary to present the Company’s financial statements on a consolidated basis. The following condensed consolidating
financial information should be read in conjunction with the Company's consolidated financial statements.
BioHiTech Global, Inc. and Subsidiaries
|
Notes to Unaudited Condensed Consolidated Financial Statements
|
For the Three and Months Ended March 31, 2020 and 2019 and as of March 31, 2020 and December 31, 2019
|
Condensed Consolidating Balance Sheet
as of March 31, 2020
|
|
Parent
and other
Subsidiaries
|
|
|
Entsorga
West
Virginia LLC
|
|
|
Eliminations
|
|
|
Consolidated
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash
|
|
$
|
1,917,803
|
|
|
$
|
17,043
|
|
|
$
|
-
|
|
|
$
|
1,934,846
|
|
Restricted cash
|
|
|
-
|
|
|
|
1,137,714
|
|
|
|
-
|
|
|
|
1,137,714
|
|
Other current assets
|
|
|
1,640,754
|
|
|
|
1,507,533
|
|
|
|
(123,459
|
)
|
|
|
3,024,828
|
|
Current assets
|
|
|
3,558,557
|
|
|
|
2,662,290
|
|
|
|
(123,459
|
)
|
|
|
6,097,388
|
|
Restricted cash
|
|
|
-
|
|
|
|
2,563,978
|
|
|
|
-
|
|
|
|
2,563,978
|
|
HEBioT facility and other fixed assets
|
|
|
1,682,271
|
|
|
|
36,951,832
|
|
|
|
-
|
|
|
|
38,634,103
|
|
Operating lease right of use assets
|
|
|
24,325
|
|
|
|
894,260
|
|
|
|
-
|
|
|
|
918,585
|
|
MBT facility development and license costs
|
|
|
6,278,938
|
|
|
|
1,764,000
|
|
|
|
-
|
|
|
|
8,042,938
|
|
Investment in subsidiaries and intercompany accounts
|
|
|
13,069,738
|
|
|
|
(2,450,776
|
)
|
|
|
(10,618,962
|
)
|
|
|
-
|
|
Goodwill
|
|
|
-
|
|
|
|
58,000
|
|
|
|
-
|
|
|
|
58,000
|
|
Other assets
|
|
|
48,849
|
|
|
|
-
|
|
|
|
-
|
|
|
|
48,849
|
|
Total assets
|
|
$
|
24,662,678
|
|
|
$
|
42,443,584
|
|
|
$
|
(10,742,421
|
)
|
|
$
|
56,363,841
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and stockholders’ equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line of credit
|
|
$
|
1,481,356
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
1,481,356
|
|
Current portion of Debts and Bonds
|
|
|
4,241,578
|
|
|
|
2,860,000
|
|
|
|
-
|
|
|
|
7,101,578
|
|
Other current liabilities
|
|
|
3,790,497
|
|
|
|
5,637,288
|
|
|
|
-
|
|
|
|
9,427,785
|
|
Current liabilities
|
|
|
9,513,431
|
|
|
|
8,497,288
|
|
|
|
-
|
|
|
|
18,010,719
|
|
Notes payable and other debts
|
|
|
962,011
|
|
|
|
-
|
|
|
|
-
|
|
|
|
962,011
|
|
Accrued interest
|
|
|
1,567,311
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,567,311
|
|
Non-current lease liabilities
|
|
|
-
|
|
|
|
916,973
|
|
|
|
-
|
|
|
|
916,973
|
|
WV EDA bonds
|
|
|
-
|
|
|
|
28,392,733
|
|
|
|
-
|
|
|
|
28,392,733
|
|
Total liabilities
|
|
|
12,042,753
|
|
|
|
37,806,994
|
|
|
|
-
|
|
|
|
49,849,747
|
|
Redeemable preferred stock
|
|
|
726,553
|
|
|
|
-
|
|
|
|
-
|
|
|
|
726,553
|
|
Stockholder’s equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Attributable to parent
|
|
|
1,264,636
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,264,636
|
|
Attributable to non-controlling interests
|
|
|
10,628,736
|
|
|
|
4,636,590
|
|
|
|
(10,742,421
|
)
|
|
|
4,522,905
|
|
Stockholders’ equity
|
|
|
11,893,372
|
|
|
|
4,636,590
|
|
|
|
(10,742,421
|
)
|
|
|
5,787,541
|
|
Total liabilities and stockholders’ equity
|
|
$
|
24,662,678
|
|
|
$
|
42,443,584
|
|
|
$
|
(10,742,421
|
)
|
|
$
|
56,363,841
|
|
Condensed Consolidating Statement of
Operations for the three months ended March 31, 2020
|
|
Parent
and other
Subsidiaries
|
|
|
Entsorga
West
Virginia LLC
|
|
|
Eliminations
|
|
|
Consolidated
|
|
Revenue
|
|
$
|
869,209
|
|
|
$
|
490,132
|
|
|
$
|
-
|
|
|
$
|
1,359,341
|
|
Operating expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
HEBioT
|
|
|
-
|
|
|
|
812,427
|
|
|
|
-
|
|
|
|
812,427
|
|
Rental, service and maintenance expense
|
|
|
260,835
|
|
|
|
-
|
|
|
|
-
|
|
|
|
260,835
|
|
Equipment
|
|
|
146,404
|
|
|
|
-
|
|
|
|
-
|
|
|
|
146,404
|
|
Selling, general and administrative
|
|
|
1,668,780
|
|
|
|
249,643
|
|
|
|
-
|
|
|
|
1,918,423
|
|
Depreciation and amortization
|
|
|
124,733
|
|
|
|
490,469
|
|
|
|
-
|
|
|
|
615,202
|
|
Total operating expenses
|
|
|
2,200,752
|
|
|
|
1,552,539
|
|
|
|
-
|
|
|
|
3,753,291
|
|
Loss from operations
|
|
|
(1,331,543
|
)
|
|
|
(1,062,407
|
)
|
|
|
-
|
|
|
|
(2,393,950
|
)
|
Other (income) expenses, net
|
|
|
348,228
|
|
|
|
651,796
|
|
|
|
-
|
|
|
|
1,000,024
|
|
Net loss
|
|
$
|
(1,679,771
|
)
|
|
$
|
(1,714,203
|
)
|
|
$
|
-
|
|
|
$
|
(3,393,974
|
)
|
BioHiTech Global, Inc. and Subsidiaries
|
Notes to Unaudited Condensed Consolidated Financial Statements
|
For the Three and Months Ended March 31, 2020 and 2019 and as of March 31, 2020 and December 31, 2019
|
Condensed Consolidating Statement of Cash Flows for the three
months ended March 31, 2020
|
|
Parent
and other
Subsidiaries
|
|
|
Entsorga
West
Virginia LLC
|
|
|
Eliminations
|
|
|
Consolidated
|
|
Cash flows used in operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(1,679,771
|
)
|
|
$
|
(1,714,203
|
)
|
|
$
|
|
|
|
$
|
(3,393,974
|
)
|
Non-cash adjustments to reconcile net loss to net cash used in operations
|
|
|
550,567
|
|
|
|
535,776
|
|
|
|
|
|
|
|
1,086,343
|
|
Changes in operating assets and liabilities
|
|
|
(1,433,781
|
)
|
|
|
1,225,938
|
|
|
|
|
|
|
|
(207,843
|
)
|
Net cash used in operations
|
|
|
(2,562,985
|
)
|
|
|
47,511
|
|
|
|
|
|
|
|
(2,515,474
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flow used in investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of construction in-progress, equipment, fixtures and vehicles
|
|
|
(2,649
|
)
|
|
|
(18,200
|
)
|
|
|
|
|
|
|
(20,849
|
)
|
Other investing activities
|
|
|
(24,509
|
)
|
|
|
-
|
|
|
|
|
|
|
|
(24,509
|
)
|
Net cash used in investing activities
|
|
|
(27,158
|
)
|
|
|
(18,200
|
)
|
|
|
|
|
|
|
(45,358
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuances of debt and equity
|
|
|
2,695,450
|
|
|
|
-
|
|
|
|
|
|
|
|
2,695,450
|
|
Repayments of debt
|
|
|
(1,460
|
)
|
|
|
-
|
|
|
|
|
|
|
|
(1,460
|
)
|
Net cash provided by financing activities
|
|
|
2,693,990
|
|
|
|
-
|
|
|
|
|
|
|
|
2,693,990
|
|
Effect of exchange rate on cash
|
|
|
(33,572
|
)
|
|
|
-
|
|
|
|
|
|
|
|
(33,572
|
)
|
Cash – beginning of period (restricted and unrestricted)
|
|
|
1,847,526
|
|
|
|
3,689,426
|
|
|
|
|
|
|
|
5,536,952
|
|
Cash – end of period (restricted and unrestricted)
|
|
$
|
1,917,803
|
|
|
$
|
3,718,735
|
|
|
$
|
|
|
|
$
|
5,636,538
|
|
Condensed Consolidating Balance Sheet
as of December 31, 2019
|
|
Parent
and other
Subsidiaries
|
|
|
Entsorga
West
Virginia LLC
|
|
|
Eliminations
|
|
|
Consolidated
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash
|
|
$
|
1,847,526
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
1,847,526
|
|
Restricted cash
|
|
|
-
|
|
|
|
1,133,581
|
|
|
|
-
|
|
|
|
1,133,581
|
|
Other current assets
|
|
|
1,697,910
|
|
|
|
1,116,821
|
|
|
|
(64,669
|
)
|
|
|
2,750,062
|
|
Current assets
|
|
|
3,545,436
|
|
|
|
2,250,402
|
|
|
|
(64,669
|
)
|
|
|
5,731,169
|
|
Restricted cash
|
|
|
-
|
|
|
|
2,555,845
|
|
|
|
-
|
|
|
|
2,555,845
|
|
HEBioT facility and other fixed assets
|
|
|
1,753,730
|
|
|
|
37,392,601
|
|
|
|
-
|
|
|
|
39,146,331
|
|
Operating lease right of use assets
|
|
|
48,021
|
|
|
|
897,026
|
|
|
|
-
|
|
|
|
945,047
|
|
MBT facility development and license costs
|
|
|
6,254,429
|
|
|
|
1,795,500
|
|
|
|
-
|
|
|
|
8,049,929
|
|
Investment in subsidiaries
|
|
|
10,864,783
|
|
|
|
-
|
|
|
|
(10,864,783
|
)
|
|
|
-
|
|
Goodwill
|
|
|
-
|
|
|
|
58,000
|
|
|
|
-
|
|
|
|
58,000
|
|
Other assets
|
|
|
53,726
|
|
|
|
-
|
|
|
|
-
|
|
|
|
53,726
|
|
Total assets
|
|
$
|
22,520,125
|
|
|
$
|
44,949,374
|
|
|
$
|
(10,929,452
|
)
|
|
$
|
56,540,047
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and stockholders’ equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line of credit
|
|
$
|
1,479,848
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
1,479,848
|
|
Current portion of WV EDA Bonds
|
|
|
-
|
|
|
|
1,390,000
|
|
|
|
-
|
|
|
|
1,390,000
|
|
Other current liabilities
|
|
|
2,387,916
|
|
|
|
6,475,985
|
|
|
|
(650,894
|
)
|
|
|
8,213,007
|
|
Current liabilities
|
|
|
3,867,764
|
|
|
|
7,865,985
|
|
|
|
(650,894
|
)
|
|
|
11,082,855
|
|
Notes payable and other debts
|
|
|
5,118,125
|
|
|
|
-
|
|
|
|
-
|
|
|
|
5,118,125
|
|
Accrued interest
|
|
|
1,510,193
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,510,193
|
|
Non-current lease liabilities
|
|
|
-
|
|
|
|
915,170
|
|
|
|
-
|
|
|
|
915,170
|
|
WV EDA bonds
|
|
|
-
|
|
|
|
29,817,426
|
|
|
|
-
|
|
|
|
29,817,426
|
|
Total liabilities
|
|
|
10,496,082
|
|
|
|
38,598,581
|
|
|
|
(650,894
|
)
|
|
|
48,443,769
|
|
Redeemable preferred stock
|
|
|
726,553
|
|
|
|
-
|
|
|
|
-
|
|
|
|
726,553
|
|
Stockholder’s equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Attributable to parent
|
|
|
2,024,143
|
|
|
|
-
|
|
|
|
-
|
|
|
|
2,024,143
|
|
Attributable to non-controlling interests
|
|
|
9,273,347
|
|
|
|
6,350,793
|
|
|
|
(10,278,558
|
)
|
|
|
5,345,582
|
|
Stockholders’ equity
|
|
|
11,297,490
|
|
|
|
6,350,793
|
|
|
|
(10,278,558
|
)
|
|
|
7,369,725
|
|
Total liabilities and stockholders’ equity
|
|
$
|
22,520,125
|
|
|
$
|
44,949,374
|
|
|
$
|
(10,929,452
|
)
|
|
$
|
56,540,047
|
|
BioHiTech Global, Inc. and Subsidiaries
|
Notes to Unaudited Condensed Consolidated Financial Statements
|
For the Three and Months Ended March 31, 2020 and 2019 and as of March 31, 2020 and December 31, 2019
|
Condensed Consolidating Statement of
Operations for the three months ended March 31, 2019
|
|
Parent
and other
Subsidiaries
|
|
|
Entsorga
West
Virginia LLC
|
|
|
Eliminations
|
|
|
Consolidated
|
|
Revenue
|
|
$
|
737,701
|
|
|
$
|
-
|
|
|
$
|
|
|
|
$
|
737,701
|
|
Operating expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rental, service and maintenance expense
|
|
|
203,203
|
|
|
|
-
|
|
|
|
-
|
|
|
|
203,203
|
|
Selling, general and administrative
|
|
|
2,057,247
|
|
|
|
269,115
|
|
|
|
-
|
|
|
|
2,326,362
|
|
Depreciation and amortization
|
|
|
129,439
|
|
|
|
-
|
|
|
|
-
|
|
|
|
129,439
|
|
Total operating expenses
|
|
|
2,389,889
|
|
|
|
269,115
|
|
|
|
-
|
|
|
|
2,659,004
|
|
Loss from operations
|
|
|
(1,652,188
|
)
|
|
|
(269,115
|
)
|
|
|
-
|
|
|
|
(1,921,303
|
)
|
Other expenses
|
|
|
311,989
|
|
|
|
27,875
|
|
|
|
-
|
|
|
|
339,864
|
|
Net loss
|
|
$
|
(1,964,177
|
)
|
|
$
|
(296,990
|
)
|
|
$
|
-
|
|
|
$
|
(2,261,167
|
)
|
Condensed Consolidating Statement of
Cash Flows for the three months ended March 31, 2019
|
|
Parent
and other
Subsidiaries
|
|
|
Entsorga
West
Virginia LLC
|
|
|
Eliminations
|
|
|
Consolidated
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(1,964,177
|
)
|
|
$
|
(296,990
|
)
|
|
$
|
-
|
|
|
$
|
(2,261,167
|
)
|
Adjustments to reconcile net loss to net cash used in operations
|
|
|
892,106
|
|
|
|
31,090
|
|
|
|
-
|
|
|
|
923,196
|
|
Changes in operating assets and liabilities
|
|
|
63,732
|
|
|
|
61,590
|
|
|
|
-
|
|
|
|
125,322
|
|
Net cash used in operations
|
|
|
(1,008,339
|
)
|
|
|
(204,310
|
)
|
|
|
-
|
|
|
|
(1,212,649
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flow from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Construction in process and acquisitions of property and equipment
|
|
|
188
|
|
|
|
(2,795,012
|
)
|
|
|
-
|
|
|
|
(2,794,824
|
)
|
Capital contribution to Entsorga West Virginia, LLC
|
|
|
(1,000,000
|
)
|
|
|
-
|
|
|
|
1,000,000
|
|
|
|
-
|
|
Other investing activities
|
|
|
52,400
|
|
|
|
-
|
|
|
|
-
|
|
|
|
52,400
|
|
Net cash used in investing activities
|
|
|
(947,412
|
)
|
|
|
(2,795,012
|
)
|
|
|
1,000,000
|
|
|
|
(2,742,424
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuances of debt and equity
|
|
|
900,000
|
|
|
|
1,000,000
|
|
|
|
(1,000,000
|
)
|
|
|
900,000
|
|
Repayments of debt
|
|
|
(2,264
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
(2,264
|
)
|
Deferred financing costs incurred
|
|
|
-
|
|
|
|
(43,941
|
)
|
|
|
-
|
|
|
|
(43,941
|
)
|
Net cash provided by financing activities
|
|
|
897,736
|
|
|
|
956,059
|
|
|
|
(1,000,000
|
)
|
|
|
853,795
|
|
Effect of exchange rate on cash
|
|
|
19,851
|
|
|
|
-
|
|
|
|
-
|
|
|
|
19,851
|
|
Cash – beginning of period (restricted and unrestricted)
|
|
|
2,410,708
|
|
|
|
6,715,672
|
|
|
|
-
|
|
|
|
9,126,380
|
|
Cash – end of period (restricted and unrestricted)
|
|
$
|
1,372,544
|
|
|
$
|
4,672,409
|
|
|
$
|
-
|
|
|
$
|
6,044,953
|
|